Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments (Tables)
|
3 Months Ended |
Mar. 31, 2024 |
|---|
| Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments |
|
| Schedule of marketable investment securities, restricted cash and cash equivalents, and other investments |
| | | | | | | | | As of | | | March 31, | | December 31, | | | 2024 | | 2023 | | | | (In thousands) | Marketable investment securities: | | | | | | | Current marketable investment securities: | | | | | | | Strategic - available-for-sale | | $ | 149 | | $ | 144 | Strategic - trading/equity | | | 144,419 | | | 176,205 | Other | | | 8,081 | | | 446,695 | Total current marketable investment securities | | | 152,649 | | | 623,044 | Restricted marketable investment securities (1) | | | 31,266 | | | 27,840 | Total marketable investment securities | | | 183,915 | | | 650,884 | | | | | | | | Restricted cash and cash equivalents (1) | | | 89,713 | | | 90,225 | | | | | | | | Other investments, net: | | | | | | | Equity method investments | | | 161,657 | | | 169,038 | Cost method investments | | | 108,333 | | | 106,134 | Fair value method and other debt investments | | | 39,199 | | | 39,198 | Total other investment securities, net | | | 309,189 | | | 314,370 | | | | | | | | Total marketable investment securities, restricted cash and cash equivalents, and other investment securities, net | | $ | 582,817 | | $ | 1,055,479 |
| (1) | Restricted marketable investment securities and restricted cash and cash equivalents are included in “Restricted cash, cash equivalents and marketable investment securities” on our Condensed Consolidated Balance Sheets. |
|
| Schedule of fair value measurements |
| | | | | | | | | | | | | | | | | | | | | | | | | | | As of | | | March 31, 2024 | | December 31, 2023 | | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | | | (In thousands) | Cash equivalents (including restricted) | | $ | 356,899 | | $ | 125,445 | | $ | 231,454 | | $ | — | | $ | 1,692,849 | | $ | 573,504 | | $ | 1,119,345 | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | Debt securities (including restricted): | | | | | | | | | | | | | | | | | | | | | | | | | U.S. Treasury and agency securities | | $ | 17,910 | | $ | 17,910 | | $ | — | | $ | — | | $ | 65,172 | | $ | 65,172 | | $ | — | | $ | — | Commercial paper | | | 6,100 | | | — | | | 6,100 | | | — | | | 290,398 | | | — | | | 290,398 | | | — | Corporate securities | | | 15,032 | | | — | | | 15,032 | | | — | | | 114,265 | | | — | | | 114,265 | | | — | Other | | | 454 | | | — | | | 305 | | | 149 | | | 4,844 | | | — | | | 4,700 | | | 144 | Equity securities | | | 144,419 | | | 134,689 | | | 9,730 | | | — | | | 176,205 | | | 166,481 | | | 9,724 | | | — | Total | | $ | 183,915 | | $ | 152,599 | | $ | 31,167 | | $ | 149 | | $ | 650,884 | | $ | 231,653 | | $ | 419,087 | | $ | 144 |
|
| Schedule of gains and losses on sales and changes in carrying amounts of investments and other |
| | | | | | | | | | For the Three Months Ended | | | | March 31, | | Other, net: | | 2024 | | 2023 | | | | | (In thousands) | Marketable and non-marketable investment securities - realized and unrealized gains (losses) | | $ | (23,893) | | $ | (7,417) | | Derivative instruments - net realized and/or unrealized gains (losses) | | | — | | | (28,961) | | Gains (losses) related to early redemption of debt | | | — | | | 49 | | Foreign currency transaction gains (losses) | | | (627) | | | 3,172 | | Equity in earnings (losses) of affiliates | | | (2,786) | | | (2,002) | | Other | | | 1,196 | | | 398 | | Total | | $ | (26,110) | | $ | (34,761) | | | | | | | | | |
|